2017
DOI: 10.1002/mabi.201700103
|View full text |Cite
|
Sign up to set email alerts
|

An Injectable System for Local and Sustained Release of Antimicrobial Agents in the Periodontal Pocket

Abstract: Periodontitis treatments usually require local administration of antimicrobial drugs with the aim to reduce the bacterial load inside the periodontal pocket. Effective pharmaceutical treatments may require sustained local drug release for several days in the site of interest. Currently available solutions are still not able to fulfill the clinical need for high-quality treatments, mainly in terms of release profiles and patients' comfort. This work aims to fill this gap through the development of an in situ ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 41 publications
(51 reference statements)
0
13
0
1
Order By: Relevance
“…176 In recent research studies, the micrometer-sized β-CD-based hydrogel (bCD-Jef-MPs) system also achieved sustained release of chlorhexidine digluconate, thus treating periodontitis lesions became effective. 177 The prolonged release has made it possible to decrease its dosage. Therefore, its side effects were reduced.…”
mentioning
confidence: 99%
“…176 In recent research studies, the micrometer-sized β-CD-based hydrogel (bCD-Jef-MPs) system also achieved sustained release of chlorhexidine digluconate, thus treating periodontitis lesions became effective. 177 The prolonged release has made it possible to decrease its dosage. Therefore, its side effects were reduced.…”
mentioning
confidence: 99%
“…Nowadays, several intra-pocket drug delivery systems, such as solutions, gels, fibers, films and inserts, have been investigated and, sometimes, proposed on the market. Nevertheless, such systems show some limitations resulting in the reduced treatment efficacy and/or low patient compliance; for example, in the case of solutions, the drug at the site of infection/inflammation has poor retention, and the drug release rate is not controlled, while, in the case of inserts, there is pain caused by their insertion in the sub-gingival areas [ 79 , 80 ].…”
Section: Buccal Routementioning
confidence: 99%
“…For these reasons, in situ gelling systems, in particular thermo-sensitive ones, have been proposed as valid candidates for local intra-pocket drug delivery. Being fluids before and during administration, they can be easily injected by means of a periodontal syringe, allowing the formulation to get access to the entire pocket; once administered, they undergo sol–gel phase transition resulting in soft but robust gels that are able to prolong the release rate of the drug, residing at the site of action for a desirable period of time ( Figure 4 ) [ 79 , 81 ].…”
Section: Buccal Routementioning
confidence: 99%
See 1 more Smart Citation
“…O ácido polilático (PLA), ácido poliglicólico (PGA), poli (ácido lático-co-ácido glicólico) (PLGA) e a poli (ɛ-caprolactona) (PCL) são alguns exemplos de polímeros que vêm sendo utilizados na confecção de nanofibras pelo processo de eletrofiação, entretanto, seu uso na medicina começou há muitos anos, por exemplo, em suturas absorvíveis e em sistemas de osteossíntese (Huang et al, 2003;Felice et al, 2014; Al-Moraissi; Ellis, 2015; Prakasam et al, 2017). Na odontologia, os polímeros biodegradáveis têm destaque na área de periodontia, principalmente na liberação de antibióticos e antissépticos tais como: tetraciclina (Shahi et al, 2017), metronidazol (Varshosaz et al, 2002) e clorexidina (Yue et al, 2004;Morelli et al, 2017). Na regeneração tecidual eles também desempenham um papel importante na repopulação celular guiada pela formação de arcabouços e liberação de fatores de crescimento.…”
Section: Polímeros Reabsorvíveisunclassified